Sector ratings Charles River Laboratories International, Inc.
Equities
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 148.40 USD | +0.69% |
|
+2.31% | -19.61% |
Main competitors
| Fundamentals (Composite) | Global Valuation (Composite) | Consensus (Composite) | Financial estimates revisions (Composite) | Visibility (Composite) | Investor (Composite) | ESG MSCI | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
A | 7.24B | ||||||||
AAA | 48.77B | ||||||||
| - | 30.55B | ||||||||
AA | 26.84B | ||||||||
BBB | 25.49B | ||||||||
AA | 12.34B | ||||||||
AA | 11.71B | ||||||||
AAA | 10.12B | ||||||||
| - | AA | 9.93B | |||||||
BBB | 8.87B | ||||||||
A | 7.73B | ||||||||
AA | 5.68B | ||||||||
AA | 5.39B | ||||||||
| Average | AA | 16.2B | |||||||
| Weighted average by Cap. | AA |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition